iifl-logo

Mirae Asset Healthcare Fund Direct G

Mirae Asset Healthcare Fund Direct G

Fund Name

Mirae Asset Mutual Fund

Scheme Name

Mirae Asset Healthcare Fund Direct G

AMC

Mirae Asset Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

11-Jun-2018

Fund Manager

Vrijesh Kasera

Net Assets (Rs. cr)

2939.23

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Mirae Asset Healthcare Fund Direct G - Nav Details

Nav Date

:  12-Jun-2026

NAV [Rs.]

:  47.747

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

1.00% - If redeemed within 1 year (365 days) from the date of allotment Nil - If redeemed after 1 year (365 days) from the date of allotment

Mirae Asset Healthcare Fund Direct G- NAV Chart

Mirae Asset Healthcare Fund Direct G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
1.1
0.32
6.79
10.98
12.52
26.4
15.52
21.66
Category Avg
-1.48
3.96
6.4
5.15
10
23.45
13.95
14.83
Category Best
-0.02
6.29
10.67
11.79
20.13
27.28
16.38
29.32
Category Worst
-2.63
-0.92
-0.53
-2.66
1.77
19.09
10.35
-1.67

Mirae Asset Healthcare Fund Direct G- Latest Dividends

No Records Found

Mirae Asset Healthcare Fund Direct G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
Wockhardt21,796
Rubicon Research30,747
Syngene Intl.2,181

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology11.131912104344.02
EquityDivi's Lab.Pharmaceuticals & Biotechnology8.02372182248.13
EquityJ B Chemicals &Pharmaceuticals & Biotechnology6.44919340199.25
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology6.39869397197.77
EquityApollo HospitalsHealthcare Services6.03228296186.66
EquityLaurus LabsPharmaceuticals & Biotechnology4.35987748134.53
EquityLupinPharmaceuticals & Biotechnology4.27582670132.13
EquityDr Reddy's LabsPharmaceuticals & Biotechnology4.261012180131.93
EquityAurobindo PharmaPharmaceuticals & Biotechnology4.11892330127.28
EquityFortis Health.Healthcare Services3.881293084120.05
EquityAlkem LabPharmaceuticals & Biotechnology3.57200895110.45
EquityKrishna Institu.Healthcare Services3.541445186109.66
EquityOneSource Speci.Pharmaceuticals & Biotechnology3.25551345100.59
EquityERIS LifesciencePharmaceuticals & Biotechnology3.24717262100.34
EquitySai LifePharmaceuticals & Biotechnology3.2285932999.68
EquityCiplaPharmaceuticals & Biotechnology3.2170861099.27
EquityAster DM Health.Healthcare Services3.09131439395.73
EquityIpca Labs.Pharmaceuticals & Biotechnology3.0261235093.34
EquityDr Lal PathlabsHealthcare Services2.5448848978.51
EquityMax HealthcareHealthcare Services2.3475147772.52
EquityGland PharmaPharmaceuticals & Biotechnology2.2230574268.79
EquityMankind PharmaPharmaceuticals & Biotechnology2.0726944164.00
EquityNarayana HrudayaHealthcare Services1.3321768841.23
EquityAnthem BiosciencPharmaceuticals & Biotechnology1.1948795237.08
EquityNeogen ChemicalsChemicals & Petrochemicals0.6110296119.13
EquityBioconPharmaceuticals & Biotechnology0.5640471917.34
EquityDeepak NitriteChemicals & Petrochemicals0.499153915.39
EquityTorrent Pharma.Pharmaceuticals & Biotechnology0.453219114.19
EquitySudeep PharmaChemicals & Petrochemicals0.3715429811.45

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
Mirae Asset Mutual Fund
Incorporation Date:
20-Nov-2006
Total Assets Managed (Cr.):
2,27,883.54
Trustee/s:
M.L.Soneji, Mirae Asset Trustee Compa
Chairman:
NA
CEO / MD:
Swarup Anand Mohanty
CIO:
NA
President:
NA
Director/s:
Yogesh Chadha, Mr. Swarup Mohanty
Compliance Officer/s:
NA
Investor Service Officer/s:
NA
Fund Manager/s:
Vrijesh Kasera
Auditors:
Ms/ M P Chitale & CO

OTHER INFORMATION

Registered Office:
Unit 606,6th Flr,Windsor Off. CST Road,Kalina, Santacruz(E),Mumbai-400098
Contact Nos:
022-67800300
Fax:
022-67253942
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.